Showing results (101-110 of 178) with videos related to

Sort By:
Pageof 18
Pediatric Dermatology|July 7, 2026
Supplemental Nutrition Assistance Program (SNAP), Skin Health, and Equity in Pediatric Populations: Integrating Nutrition Policy Into Dermatologic CareUmayr R Shaikh, Harrison P Nguyen, Christopher G Richter, et al.
Nutrients|October 14, 2023
Post-Exercise Protein Intake May Reduce Time in Hypoglycemia Following Moderate-Intensity Continuous Exercise among Adults with Type 1 DiabetesFranklin R Muntis, Elizabeth J Mayer-Davis, Saame R Shaikh, et al.
Cureus|March 15, 2021
Medical and Psychosocial Challenges Associated with Breast Cancer SurvivorshipRaja Rahool, Ghulam Haider, Aisha Shahid, et al.
Experimental Eye Research|November 25, 2010
Mitogen-activated protein kinase phosphatase-1 (MKP-1) in retinal ischemic preconditioningJohn C Dreixler, Anthony Bratton, Eugenie Du, et al.
Journal of Health Communication|August 17, 2011
Realizing the promise of Web 2.0: engaging community intelligenceBradford W Hesse, Mary O'Connell, Erik M Augustson, et al.
Circulation|June 15, 2007
Emergency department physician activation of the catheterization laboratory and immediate transfer to an immediately available catheterization laboratory reduce door-to-balloon time in ST-elevation myocardial infarctionUmesh N Khot, Michele L Johnson, Curtis Ramsey, et al.
Sensors and Actuators. B, Chemical|February 18, 2010
Passive Microfluidic device for Sub Millisecond MixingZonghuan Lu, Jay McMahon, Hisham Mohamed, et al.
Translational Behavioral Medicine|September 28, 2013
Adapting research-tested computerized tailored interventions for broader dissemination and implementationCynthia Vinson, Timothy Bickmore, David Farrell, et al.
Expert Opinion on Biological Therapy|July 11, 2008
Biofunctionalized targeted nanoparticles for therapeutic applicationsAndrew Z Wang, Frank Gu, Liangfang Zhang, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 25, 2011
Clinical experience with Optivate®, high-purity factor VIII (FVIII) product with von Willebrand factor (VWF) in young children with haemophilia AM Matysiak, H Bobrowska, W Balwierz, et al.
Pageof 18